BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9216670)

  • 1. The effects of cantharidin analogues on xanthine oxidase.
    Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
    Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
    Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cantharidin-based small molecules as potential therapeutic agents.
    Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
    Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
    Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
    J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
    Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
    ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
    McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical uses of mylabris in ancient China and recent studies.
    Wang GS
    J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
    Yeh CB; Su CJ; Hwang JM; Chou MC
    Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.
    Hu L; Hu H; Wu W; Chai X; Luo J; Wu Q
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4013-5. PubMed ID: 21620698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
    Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
    Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of xanthine oxidase by benzothiazinone analogues.
    Sheu SY; Lin CY; Wu JD; Chiang HC
    Anticancer Res; 1999; 19(1A):119-23. PubMed ID: 10226532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of plant growth regulators on xanthine oxidase.
    Sheu SY; Chiang HC
    Anticancer Res; 1996; 16(1):311-5. PubMed ID: 8615627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of xanthine oxidase by purpurogallin and silymarin group.
    Sheu SY; Lai CH; Chiang HC
    Anticancer Res; 1998; 18(1A):263-7. PubMed ID: 9568088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds.
    Sheu SY; Chiang HC
    Anticancer Res; 1997; 17(5A):3293-7. PubMed ID: 9413162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
    Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
    Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential in vitro inhibition studies of some cerium vanadate derivatives on xanthine oxidase.
    Kaya MO; Kaya Y; Çelik G; Kurtuluş F; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):286-9. PubMed ID: 24964345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the study of Cantharidin and its derivatives].
    Liu J; Gao J; Liu X
    Zhong Yao Cai; 2003 Jun; 26(6):453-5. PubMed ID: 14666949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.